Financials
- Market Capitalization 452.96 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.98
売上高対価格比率
4.57
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2969 | AVIR Atea Pharmaceuticals, Inc. - common stock | 5.70 USD | +3.83% | +4.01% | +23.64% | +77.57% | 457.17 M USD | ||
| 2976 | EVMN Evommune, Inc. Common Stock | 12.50 USD | +0.08% | -10.65% | +7.39% | -27.83% | 453.65 M USD | ||
| 2981 | GALT Galectin Therapeutics Inc. - Common Stock | 4.48 USD | +7.43% | +7.95% | +51.35% | 0.00% | 451.81 M USD | ||
| 2985 | OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -0.75% | -7.04% | +3.13% | +26.92% | 447.63 M USD |